Trial Parameters
Brief Summary
The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.
Eligibility Criteria
Inclusion Criteria: 1. Patients ≥ 19 years old 2. Patients receiving Coroflex ISAR NEO stents. 3. The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site. Exclusion Criteria: 1. Patients with a mixture of other DESs 2. Terminal illness with life expectancy \<1 year. 3. Patients with cardiogenic shock